Calcium phosphate nanocoatings and nanocomposites, part 2: thin films for slow drug delivery and osteomyelitis

Nanomedicine (Lond). 2016;11(5):531-44. doi: 10.2217/nnm.15.220. Epub 2016 Feb 19.

Abstract

During the last two decades although many calcium phosphate based nanomaterials have been proposed for both drug delivery, and bone regeneration, their coating applications have been somehow slow due to the problems related to their complicated synthesis methods. In order to control the efficiency of local drug delivery of a biomaterial the critical pore sizes as well as good control of the chemical composition is pertinent. A variety of calcium phosphate based nanocoated composite drug delivery systems are currently being investigated. This review aims to give an update into the advancements of calcium phosphate nanocoatings and thin film nanolaminates. In particular recent research on PLA/hydroxyapatite composite thin films and coatings into the slow drug delivery for the possible treatment of osteomyelitis is covered.

Keywords: antibiotics; biofilm; drug delivery; hydroxyapatite; nanocoatings; nanocomposites; nanolaminates; osteomyelitis; thin films.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bone Regeneration / drug effects*
  • Calcium Phosphates / chemistry
  • Calcium Phosphates / therapeutic use*
  • Coated Materials, Biocompatible / chemistry
  • Coated Materials, Biocompatible / therapeutic use
  • Drug Delivery Systems
  • Durapatite / chemistry
  • Durapatite / therapeutic use
  • Humans
  • Nanocomposites / chemistry
  • Nanocomposites / therapeutic use*
  • Osteomyelitis / drug therapy*
  • Osteomyelitis / pathology

Substances

  • Calcium Phosphates
  • Coated Materials, Biocompatible
  • Durapatite
  • calcium phosphate